pharmaphorum

MARCH 7, 2022

A new company set up to use machine learning to find new anti-infective drugs – ArrePath – has launched onto the scene with $20 million in seed financing from a group of investors including the Boehringer Ingelheim Venture Fund. The Princeton, New Jersey-based startup will use the funding to develop its artificial intelligence and imaging based drug discovery platform, used to identify compounds with new and under-exploited mechanisms of action.

Compounding 134

Compounding 134

Policy Prescription

MARCH 11, 2022

A recent opinion from an appeals court in Manitoba, Canada sheds new and more favorable light about the CanadaDrugs-related wholesale drug importation case that was first covered a decade ago in the Wall Street Journal. The case pertained to an indictment of CanadaDrugs, Ltd. for sales of mostly misbranded (but not counterfeit drugs) and two batches of counterfeit drugs.

FDA 52

FDA 52

indispensable health

MARCH 11, 2022

A Budget Paradox: Prioritizing Pharmacy Operational Efficacy & Improving Patient Outcomes Considering the sharp decline of hospital revenues, one of the key impactors of a hospital budget is the inpatient drug spend. There have been significant increases in drug costs over the past ten years. Medication shortages, new specialty therapies, and FDA drug approvals are some of the primary factors for the rise in hospital medication expenditures.

Hospitals 52

Hospitals Patient Care FDA 52

Roots Analysis

MARCH 11, 2022

Exosomes have been of great interest in the recent years due to the discovery of their potential in so many research and analytic procedures. Exosomes are known to have some unique functions, such as their ability to alter recipient cell bioactivities, acting like intercellular messengers and also having therapeutic potential in disease diagnostics as well as targeted drug delivery.

Immunization 52

Immunization Communication 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

MARCH 11, 2022

A consortium led by the Digital Medicine Society (DiMe) has been set up to try to end inequities in access to clinical trials, focusing on the increasing number of studies that use digital devices to allow participation. The organisation has teamed up with drugmakers GlaxoSmithKline and Amgen as well as partners in the clinical research, patient engagement and data analytics sector on a project to develop the principles that can be used to make sure trials are designed from the ground up to allo

109

109

Pharma Mirror

MARCH 11, 2022

As we get older, it becomes more challenging to take care of our bodies. Injuries, aches, and pains are more likely to occur. To combat aging, it’s smart to invest in your physical health. One of the primary ways that people stay healthy in California is by receiving chiropractic care. A chiropractor in Solana Beach CA can help you maintain your health while avoiding future injuries.

52

52

Roots Analysis

MARCH 9, 2022

Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies), by the US FDA, have steadily risen. In fact, over 8,000 biological pharmaceutical products are currently under clinical investigation worldwide. .

Vaccines 52

Vaccines Dosage Immunization FDA 52

pharmaphorum

MARCH 10, 2022

Mallinckrodt’s liability problems in the US have been lightened slightly, after it agreed a $260 million deal to resolve allegations of Medicare rebate fraud and payment of illegal kickbacks. The Ireland-domiciled company was accused of illegally paying smaller drug rebates to Medicaid than were due, as well as using a charitable foundation to cover co-pays for its Acthar Gel (corticotropin) epilepsy treatment – which is not allowed under US law.

104

104

Pharma Mirror

MARCH 11, 2022

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers Tokyo: CPhI Japan 2022 returns as a SMART event – with live exhibition at the Big Sight Exhibition Center in Tokyo (20-22 April) alongside an online networking platform – as CPhI data[1] confirms the country continues to top global ‘API quality’ rankings, with Japanese respondents bullish on growth in 2022 forecasting a CAGR of 14% on average.

52

52

The deprescribing.org Blog

MARCH 9, 2022

Hello, deprescribers! We are back again after a quiet few months with some more blog content. Today we are talking about prescribing cascades with Dr. Sameera Toenjes from University of Toronto (Canada). We hope that after this interview you will have “can this symptom be caused by a drug?” imprinted on your brain (though most of you probably already do!).

Patient Care 52

Patient Care Hospitals 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Tutor

MARCH 8, 2022

Rice Ferment Filtrate in Cosmetics. About Author. Vinay Kumar Singh. . Head-Formulation. Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru. admin. Tue, 03/08/2022 - 17:07. Tags. Articles.

52

52

pharmaphorum

MARCH 6, 2022

As bluebird bio struggles to get its gene therapies over the finishing line, the company says its financial position raises “substantial doubt” about its ability to continue as a going concern. The biotech is sitting on around $442 million in liquid assets, but is expecting its cash burn in 2022 to be around $400 million, having recorded a net operating loss of $563 million last year.

FDA 99

FDA 99

Pharma Mirror

MARCH 11, 2022

Casimir Further Differentiates Emmes’ Industry-Leading Rare Disease Research Capabilities Rockville, MD, March 10, 2022 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that it has acquired Casimir, a U.S.-based CRO. Casimir has experience in more than 20 rare diseases and has worked with regulators, sponsors and patients to develop outcome measures that capture the nuan

52

52

Roots Analysis

MARCH 6, 2022

Complement System: Key Component of Immune System. Complement system was discovered in 19th century as a part of immune system responsible for tissue repair and homeostasis, thereby providing first line of defense against multiple infections. This complete process is in association with a complex and highly regulated assembly of proteins which involve several soluble and surface-bound complement components, including receptors and regulators, which are majorly generated by the liver.

Immunization 52

Immunization 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Tutor

MARCH 6, 2022

Bioferments in Formula of Personal care Products. The virtues of fermentation within the human body are well known. It is proven good techniques for food, as Kimchi, Sauerkraut, Kefir, Idli & Dosa utilizes this technique. it is also significant for beauty products. The latest trend in Cosmetics particularly Skin Care is fermented beauty products. This concept, originated in Korea, basically involves fermentation of natural ingredients like black tea, ginseng, seaweed, bamboo sap extract, red clo

52

52

pharmaphorum

MARCH 10, 2022

18 months after signing its first partnering deal with Genentech, Scenic Biotech has raised $31 million in first-round financing that it will use to take its own genetic modifier-targeted medicines into clinical trials. The Netherlands-based biotech, which is putting together a pipeline of genetic modifier drugs for cancer and rare diseases, said the new funding would also allow it to double its headcount to add clinical capabilities and move to a larger facility.

Immunization 98

Immunization 98

Pharma Mirror

MARCH 11, 2022

The healthcare professions are rewarding, stimulating, prestigious, and lucrative. Few other professionals can say that their daily task is to save lives. The post Common Risks of Working as a Healthcare Professional appeared first on Pharma Mirror Magazine.

52

52

Outsourcing Pharma

MARCH 8, 2022

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.

Immunization 52

Immunization 52

Pharmacy Friday Pearls

MARCH 9, 2022

Download PDF. Introduction . 1. Around 9,000 Americans are treated for snake bites and 5 die each year. Most are bitten by members of the Crotalinae subfamily (a.k.a. crotalids) of the pit viper family which includes copperheads, water moccasins, and rattlesnakes. 2. Crotalid envenomation’s can cause broad range of adverse effects, including local tissue, hematologic, and/or systemic effects including shock and life-threatening bleeding. 3.

Immunization 40

Immunization Packaging Labelling FDA 40

pharmaphorum

MARCH 7, 2022

The World Health Organization (WHO) announced the opening of a global biomanufacturing hub located in South Korea to provide training to low- and middle-income countries seeking to produce vaccines and other biologics, such as insulin and monoclonal antibodies. . Vaccines are a powerful tool and crucial part of fighting diseases, such as tetanus, measles, meningitis, and, recently, COVID-19.

Vaccines 98

Vaccines 98

Pharma Mirror

MARCH 7, 2022

With the recent pandemic lingering on, and the new devastating news of a potential global war, prioritizing your overall health and well-being has never been more critical. While the covid19 pandemic showed us just how important physical health and a robust immune system are, the news of the war is quickly showing us the importance of mental well-being.

Immunization 52

Immunization 52

Outsourcing Pharma

MARCH 7, 2022

The two companies, along with Datavant, will combine real-world data and decentralized platforms to yield better patient information management and insights.

52

52

Tria Health Blog

MARCH 9, 2022

Sleep Awareness Week is next week from March 13th– 19th. The National Sleep Foundation created this week to reemphasize the importance of the connection of sleep and health. Their theme this year is “Best Slept Self”.

40

40

pharmaphorum

MARCH 9, 2022

Sanofi and Sobi’s haemophilia partnership has been under competitive pressure from new therapies like Roche’s antibody Hemlibra, so the two companies are hoping a new long-acting drug candidate can revitalise the franchise. New phase 3 data on efanesoctocog alfa (also known as BIVV001) has met its objectives in a phase 3 study, providing protection from bleeding episodes in patients with haemophilia A with once-weekly dosing.

Labelling 97

Labelling FDA 97

Med Ed 101

MARCH 9, 2022

Alpha-blockers (i.e., tamsulosin) are commonly seen in male patients, as they are used to treat symptoms of benign prostatic hyperplasia (BPH; the only FDA-approved indication currently). Because of this, there is no doubt a prescription sent to the pharmacy for a female may raise some speculation. In recent years, uroselective alpha-blockers have been used for […].

FDA 40

FDA Labelling 40

Outsourcing Pharma

MARCH 7, 2022

The business tech companyâs Pharmaceutical Supply Chain Vision Study gauges pharma and patient perceptions, including key concerns and areas for improvement.

52

52

Pharma Times

MARCH 11, 2022

93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks but this has fallen to just 75%

47

47

pharmaphorum

MARCH 8, 2022

To celebrate International Women’s Day, we speak to design engineer at Envair Technology Darina Shopova; managing director, UK & ROI at Healthcare Business of Merck Doina Ionescu; and vice president of clinical development, medical, and regulatory affairs, Novo Nordisk UK Avideh Nazeri about their careers, how their field is progressing and how the industry can encourage more women and girls to pursue roles in STEM.

Hospitals 96

Hospitals Communication 96

Med Ed 101

MARCH 6, 2022

Combined hormonal contraceptives (CHCs) containing both estrogen and progestin are common go-to agents for contraception. However, on occasion, CHCs are an inappropriate choice given the multiple contraindications of estrogen. Approximately 20% of women using contraception are using progestin-only products, including progestin-only pills (POPs; also known as the “mini-pill”), depot-medroxyprogesterone acetate injection, subdermal etonogestrel implants, and […].

40

40

Outsourcing Pharma

MARCH 10, 2022

The pharma company is evaluating its Paxlovid oral treatment, intended for high-risk patients who have tested positive for the virus, in pediatric subjects.

52

52

Pharma Times

MARCH 7, 2022

Fully-automated molecular system with small footprint provides greater flexibility for laboratories without much space

46

46

pharmaphorum

MARCH 10, 2022

In little over three decades, advances in biotechnology have noticeably disrupted the development landscape of small molecule drugs. Yet, despite the immense potential of the field, biologics have remained largely untapped. Now, amid a wave of innovation, investors and drugmakers are putting their weight behind the drug class. “Biologics have revolutionised treatments for several serious diseases, some of which had no therapeutic alternatives until now,” says Antonio Magnelli, head of the Chiesi

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceutical Companies Packaging Immunization 96

pharmaphorum

MARCH 7, 2022

Young entrepreneurs launch healthcare communications company Collected Group to tackle unmet needs in healthcare professional engagement. Collected Group will offer scientific and strategic services focused on an innovative approach called omniverse communication to drive improvement in people health. London, 7 th March, 2022 – Healthcare communication entrepreneurs, Emily Harrison, and Mohammed Saleh Bham have launched Collected Group, a healthcare communication company aimed at helping b

Communication 90

Communication 90

pharmaphorum

MARCH 10, 2022

Is open, responsible research the key to translating quality science into clinical benefit as quickly as possible? We ask the AMRC’s new CEO, Nicola Perrin. Accelerating access to life changing treatments is every medical research charity’s aim – and open, responsible research is the key to doing just that. Nicola Perrin, the new CEO of AMRC, which is currently working to strengthen its focus on responsible funding, told pharmaphorum that supporting the charity sector to conduct better research

86

86